S. Korea Approves Green Cross Vaccine Against H1N1 Flu
This article was originally published in PharmAsia News
Executive SummarySouth Korean regulators gave their approval to the first Korean-produced vaccine against the H1N1 influenza virus, by Green Cross
You may also be interested in...
US FDA's Pediatric Experts, Not Review Division, Should Have Final Say On Pediatric Trials, Former Official Says
Former Associate Commissioner Janice Soreth says views of pediatric experts should take precedence over those of division directors regarding pediatric trials.
Hoping to avoid litigation discovery, sponsors ask FDA for avenue to explain patent issues during labeling discussions written record; negotiations for BsUFA III may be opportunity to create such a process.